This trial is active, not recruiting.

Conditions pulmonary disease, chronic obstructive, lung diseases, obstructive, pulmonary emphysema, bronchitis, chronic, lung diseases, disease progression
Sponsor Royal Brompton & Harefield NHS Foundation Trust
Collaborator Medical Research Council
Start date April 2011
End date September 2013
Trial size 445 participants
Trial identifier NCT01515709, 2011LF001H


Patients with Chronic Obstructive Lung Disease (COPD) often develop muscle problems, particularly in their legs which makes them more limited in what they can do. The Short Physical Performance Battery (SPPB) is a simple test of standing balance, usual walking speed and ability to stand from a chair. The SPPB may be a useful measure to predict leg function.

This study aims to evaluate whether the SPPB is comparable with current exercise tests used in COPD patients, and whether it is useful in predicting disability, death and health resource usage over time.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
Patients with a diagnosis of COPD

Primary Outcomes

Mortality rate
time frame: 36 months

Secondary Outcomes

Hospitalisation rate
time frame: 36 months
Healthcare resource usage
time frame: 36 months

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - Diagnosis of COPD Exclusion Criteria: - Any patient in whom mobility and lower limb function have been significantly affected by a neuromuscular cause (eg. motor neurone disease), severe peripheral vascular disease or amputation - Any patient whom is deemed unsafe to exercise - Patients unable to complete the SPPB, walking tests and leg strength assessments.

Additional Information

Official title Is the Short Physical Performance Battery a Useful Outcome Measure in Patients With Chronic Obstructive Pulmonary Disease ?
Principal investigator William DC Man, MRCP PhD
Trial information was received from ClinicalTrials.gov and was last updated in November 2014.
Information provided to ClinicalTrials.gov by Royal Brompton & Harefield NHS Foundation Trust.